Literature DB >> 12480376

Hot flushes.

Vered Stearns1, Lynda Ullmer, Juan F López, Yolanda Smith, Claudine Isaacs, DanielF Hayes.   

Abstract

Almost every woman and some men will encounter hot flushes during their lifetime. Despite the prevalence of the symptoms, the pathophysiology of hot flushes remains unknown. A decline in hormone concentrations might lead to alterations in brain neurotransmitters and to instability in the hypothalamic thermoregulatory setpoint. The most effective treatments for hot flushes include oestrogens and progestagens. However, many women and their physicians are reluctant to accept hormonal treatments. Women want non-pharmacological treatments but unfortunately such treatments are not very effective, and non-hormonal drugs are often associated with adverse effects. Results from recent studies showed that selective serotonin reuptake inhibitors and other similar compounds can safely reduce hot flushes. Moreover, the efficacy of these drugs provides new insight into the pathophysiology of hot flushes. In this critical review, we assess knowledge of the epidemiology, pathophysiology, and treatment of hot flushes.

Entities:  

Mesh:

Year:  2002        PMID: 12480376     DOI: 10.1016/s0140-6736(02)11774-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  93 in total

1.  Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study.

Authors:  Debra L Barton; Kelliann C Fee Schroeder; Tanima Banerjee; Sherry Wolf; Timothy Z Keith; Gary Elkins
Journal:  Menopause       Date:  2017-07       Impact factor: 2.953

2.  Taking hormone replacement therapy.

Authors:  Frances Griffiths
Journal:  BMJ       Date:  2003-10-11

Review 3.  Factors that may influence the experience of hot flushes by healthy middle-aged women.

Authors:  Ayelet Ziv-Gal; Jodi A Flaws
Journal:  J Womens Health (Larchmt)       Date:  2010-10       Impact factor: 2.681

Review 4.  Perimenopause: From Research to Practice.

Authors:  Nanette Santoro
Journal:  J Womens Health (Larchmt)       Date:  2015-12-10       Impact factor: 2.681

Review 5.  Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.

Authors:  Rodney Baber; Martha Hickey; Michelle Kwik
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

6.  A G-protein-coupled estrogen receptor is involved in hypothalamic control of energy homeostasis.

Authors:  Jian Qiu; Martha A Bosch; Sandra C Tobias; Andree Krust; Sharon M Graham; Stephanie J Murphy; Kenneth S Korach; Pierre Chambon; Thomas S Scanlan; Oline K Rønnekleiv; Martin J Kelly
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

7.  Effect of clinical trial publicity on HRT prescribing in Ireland.

Authors:  C Usher; M Teeling; K Bennett; J Feely
Journal:  Eur J Clin Pharmacol       Date:  2006-01-24       Impact factor: 2.953

8.  MODERATING EFFECT OF HYPNOTIZABILITY ON HYPNOSIS FOR HOT FLASHES IN BREAST CANCER SURVIVORS.

Authors:  Gary Elkins; William Fisher; Aimee Johnson; Joel Marcus; Jacqueline Dove; Michelle Perfect; Timothy Keith
Journal:  Contemp Hypn Integr Ther       Date:  2011-09-01

Review 9.  Supportive care for patients with early breast cancer.

Authors:  Laura García-Estévez; Ignasi Tusquets; Isabel Alvarez; César Rodríguez; Yolanda Fernández; Miguel Angel Seguí; Jesús García-Mata; Ana Lluch
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

Review 10.  A selective membrane estrogen receptor agonist maintains autonomic functions in hypoestrogenic states.

Authors:  Martin J Kelly; Oline K Rønnekleiv
Journal:  Brain Res       Date:  2013-03-25       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.